Eurofins Scientific SE

Equities

ERF

FR0014000MR3

Healthcare Facilities & Services

Real-time Euronext Paris 06:07:34 2024-03-28 am EDT 5-day change 1st Jan Change
57.98 EUR +0.98% Intraday chart for Eurofins Scientific SE +3.24% -1.70%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
European Equities Close Mixed in Monday Trading; Real Estate, Pharmaceutical Stocks Rise MT
CAC40: insignificant decline in limited volumes CF
Enzymatica Obtains CE Marking for ColdZyme Mouth Spray MT
CAC40: zero reaction to US PCE, but February ends on a high note CF
CAC40: steady ahead of US inflation figures CF
CAC40: frozen at 7.945, heavy sanction on Teleperformance CF
CAC40: remains stable despite Teleperformance's fall CF
EUROFINS SCIENTIFIC : Lackluster FCF and dividend cut weigh on the share price Alphavalue
CAC40: up slightly, driven by Bouygues and Alstom CF
CAC40: approaches 8,000, Nasdaq solid despite US stats CF
CAC40: back above 7,950, tech supports Wall-Street CF
Transcript : Eurofins Scientific SE, 2023 Earnings Call, Feb 27, 2024
CAC40: stable despite large share movements CF
US Futures Flat, European Stocks Mostly Rise DJ
Eurofins: Adjusted EBITDA down 10% by 2023 CF
Eurofins Scientific SE Reports Earnings Results for the Full Year Ended December 31, 2023 CI
CAC40: record-breaking end to the week CF
CAC40: week ends at zenith, despite hesitant W-Street CF
CAC40: record at 7,800, weekly gain of +1.5%, W-Street disappoints CF
CAC40: new all-time high, 7800 pts within reach CF
Queensland Pacific Metals' HPA US Marketing Sample Returns '5N' Purity; Shares Jump 11% MT
NeoSpectra and Eurofins QTA Collaborate to Advance On-Site Analysis Solutions for the Food Industry CI
EUROFINS SCIENTIFIC : Morgan Stanley upgrades to 'Underweight CF
Akebia Therapeutics Names Nicholas Grund as Chief Commercial Officer MT
CAC40: caution prevails ahead of several statistics CF
Chart Eurofins Scientific SE
More charts
Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products. At the end of 2022, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world. Net sales are distributed geographically as follows: Europe (52.3%), North America (37.1%) and other (10.6%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
57.42 EUR
Average target price
59.03 EUR
Spread / Average Target
+2.81%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Eurofins Scientific SE - Euronext Paris
  4. News Eurofins Scientific SE
  5. Eurofins Scientific : Fitch Assigns BBB- Rating To Eurofins, Stable Outlook